ESG compliance makes companies more attractive
ESG questions played a role when Nordic Capital invested in Leo Pharma in 2021, and the private equity firm says ESG is only becoming more and more important.
by ole andersen, kapitalwatch, translated by daniel pedersen & daniel frank christensen
In the first months of 2021, when Nordic Capital put EUR 450m on the table to get an ownership share of less than 25% in Danish pharmaceutical firm LEO Pharma, one might be have been forgiven for assuming that questions concerning sustainability, CO2 emissions, and leadership diversity were absent from talks.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Lundbeck ties bank loans to sustainability targets
For subscribers
